(CORT) Corcept Therapeutics - Performance 137.1% in 12m
CORT performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
81.78%
#3 in Peer-Group
Rel. Strength
95.66%
#335 in Stock-Universe
Total Return 12m
137.09%
#11 in Peer-Group
Total Return 5y
348.10%
#7 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 64.3 |
| P/E Forward | 57.8 |
| High / Low | USD |
|---|---|
| 52 Week High | 114.22 USD |
| 52 Week Low | 29.90 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 22.51 |
| Buy/Sell Signal +-5 | 1.70 |
| Support / Resistance | Levels |
|---|---|
| Support | 70.3, 59.9, 51.1, 45.6 |
| Resistance | 100.0 |
12m Total Return: CORT (137.1%) vs XLV (-4.9%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
0.45% | 137% | 348% | 64.3 | 57.8 | 0.61 | 23.7% | -5.15% |
| NVS NYSE Novartis |
4.17% | 17.7% | 84.9% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| LLY NYSE Eli Lilly |
1.71% | -15% | 415% | 63.7 | 35.8 | 1.2 | 58.2% | 18.9% |
| NOVN SW Novartis |
-0.02% | 4.07% | 52.9% | 18.4 | 13.9 | 1.36 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-4.45% | 5.6% | 53.2% | 18.6 | 8.61 | 0.38 | -25.2% | 3.11% |
| SFZN SW Siegfried Holding |
-8.77% | -8.65% | 105% | 24.2 | 23.6 | 1.48 | -42.4% | -29.3% |
| AZN NASDAQ AstraZeneca |
-3% | -5.76% | 49.2% | 27.9 | 15.4 | 0.93 | 72.4% | 45.1% |
| UCB BR UCB |
6.11% | 19.1% | 62% | 31.1 | 22 | 1.04 | -22.4% | 39.5% |
Performance Comparison: CORT vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for CORT
| Total Return (including Dividends) | CORT | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 0.45% | 1.48% | 4.37% |
| 3 Months | -2.85% | -1.89% | 14.09% |
| 12 Months | 137.09% | -4.94% | 13.68% |
| 5 Years | 348.10% | 44.79% | 112.88% |
| Trend Score (consistency of price movement) | CORT | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -6.8% | 21.7% | 83.6% |
| 3 Months | 24.3% | -20.9% | 97.2% |
| 12 Months | 91.9% | -77.4% | 45.7% |
| 5 Years | 74.6% | 87.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th46.00 | -1.01% | -3.76% |
| 3 Month | %th18.00 | -0.98% | -14.85% |
| 12 Month | %th95.00 | 149.40% | 108.56% |
| 5 Years | %th97.00 | 209.49% | 110.49% |
FAQs
Does Corcept Therapeutics (CORT) outperform the market?
Yes,
over the last 12 months CORT made 137.09%, while its related Sector, the Health Care Sector SPDR (XLV) made -4.94%.
Over the last 3 months CORT made -2.85%, while XLV made -1.89%.
Performance Comparison CORT vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
CORT vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -1.2% | -3.9% | 34.1% | 123% |
| US NASDAQ 100 | QQQ | -1.6% | -4.5% | 32.3% | 125% |
| German DAX 40 | DAX | -3.9% | -1.2% | 21.2% | 103% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -2% | -3.1% | 30.4% | 117% |
| Hongkong Hang Seng | HSI | 0.3% | -2.7% | 13.6% | 99% |
| India NIFTY 50 | INDA | -0.7% | -0.3% | 33.5% | 138% |
| Brasil Bovespa | EWZ | 2% | -3.4% | 15.8% | 133% |
CORT vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -0.3% | -3.3% | 29.9% | 113% |
| Consumer Discretionary | XLY | -0.2% | -2.1% | 42.6% | 121% |
| Consumer Staples | XLP | 1.1% | 0.7% | 35.1% | 130% |
| Energy | XLE | -1.9% | -5.8% | 41% | 135% |
| Financial | XLF | -0.2% | -2.7% | 30.7% | 110% |
| Health Care | XLV | -0.7% | -1% | 44.3% | 142% |
| Industrial | XLI | -1.8% | -3.4% | 27.4% | 111% |
| Materials | XLB | -1% | -3.9% | 30.9% | 130% |
| Real Estate | XLRE | 0.3% | 0.7% | 34.9% | 126% |
| Technology | XLK | -2.3% | -7.4% | 29.1% | 126% |
| Utilities | XLU | -1.5% | -1.8% | 32.3% | 115% |
| Aerospace & Defense | XAR | -2.3% | -4.2% | 15.5% | 87% |
| Biotech | XBI | -4.3% | -3.8% | 44% | 144% |
| Homebuilder | XHB | -1.9% | -8.9% | 39.2% | 130% |
| Retail | XRT | -0.7% | -1.6% | 40.2% | 126% |
CORT vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -2.4% | -6.32% | 46.8% | 141% |
| Natural Gas | UNG | 7.3% | 14.7% | 65.1% | 147% |
| Gold | GLD | 0.6% | 0.8% | 19.1% | 97% |
| Silver | SLV | 0.1% | 1.6% | 22.7% | 120% |
| Copper | CPER | -7% | -11.4% | 14.7% | 116% |
CORT vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 0.1% | -1.7% | 38.3% | 139% |
| iShares High Yield Corp. Bond | HYG | -0.5% | -1.1% | 37.1% | 127% |